scispace - formally typeset
A

Andrew Hardy

Researcher at Takeda Pharmaceutical Company

Publications -  3
Citations -  211

Andrew Hardy is an academic researcher from Takeda Pharmaceutical Company. The author has contributed to research in topics: Slug flow & Crystallization. The author has an hindex of 3, co-authored 3 publications receiving 166 citations. Previous affiliations of Andrew Hardy include Millennium Pharmaceuticals.

Papers
More filters
Journal ArticleDOI

Continuous-Flow Tubular Crystallization in Slugs Spontaneously Induced by Hydrodynamics

TL;DR: The slug-flow crystallizer as mentioned in this paper is a continuous crystallizer with the potential to provide improved control of crystal properties, improved process reproducibility, and reduced scale-up risk.
Journal ArticleDOI

Indirect Ultrasonication in Continuous Slug-Flow Crystallization

TL;DR: In this article, an indirect ultrasonication-assisted nucleation process is designed to vary the seed generation rate during operation independent of mass flow rate, by varying the ultrasonization power.
Journal ArticleDOI

Development and Scale-up of an Efficient Miyaura Borylation Process Using Tetrahydroxydiboron

TL;DR: In this paper, a revised Miyaura borylation process was developed using tetrahydroxydiboron that avoids the use of bis(pinacolato) diborons and hence the need to hydrolyze the resulting boronic ester to its corresponding acid.